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Tagging the cell surface receptor with ubiquitin is
believed to provide a signal for the endocytic path-
way. E3 ubiquitin ligases such as Cbl-b and Itch
have been implicated in T cell activation and toler-
ance induction. However, the underlying mecha-
nisms remain unclear. We describe that in mice defi-
cient in the E3 ubiquitin ligases Cbl-b and Itch, T cell
activation was augmented, accompanied by sponta-
neous autoimmunity. The double-mutant T cells
exhibited increased phosphorylation of the T cell
receptor-z (TCR-z) chain, whereas the endocytosis
and stability of the TCR complex were not affected.
TCR-z was polyubiquitinated via a K33-linkage,
which affected its phosphorylation and association
with the z chain-associated protein kinase Zap-70.
The juxtamembrane K54 residue in TCR-z was iden-
tified to be a primary ubiquitin conjugation site,
whose mutation increased its phosphorylation and
association of TCR-z and Zap-70. Thus, the present
study reveals unconventional K33-linked polyubiqui-
tination in nonproteolytic regulation of cell-surface-
receptor-mediated signal transduction.
INTRODUCTION
Protein ubiquitination represents a means of posttranslational
modulation by tagging the 76 amino acid small-molecule ubiqui-
tin (Ub) to a protein substrate. Ubiquitination involves a cascade
of well-defined biochemical reactions through E1, E2, and E3
enzymes (Hershko and Ciechanover, 1998). The E3 Ub ligases
are critical components in this system and specifically target
the substrates. On the basis of their structural features, E3
ligases are generally classified into RING (really interesting new
gene)-type and HECT (homologous to the E6 associated protein
C terminus)-type E3s (Kerscher et al., 2006; Pickart, 2001;
Weissman, 2001). Ub conjugation is involved in diverse biolog-
ical responses from yeast to man. Not surprisingly, the Ub
system also plays an important role in the immune system,
including lymphocyte development and activation, intracellular60 Immunity 33, 60–70, July 23, 2010 ª2010 Elsevier Inc.signal transduction, antigen presentation, and immune evasion
(Liu, 2004). Although protein ubiquitination has been historically
considered to be important for ‘‘garbage disposal’’ through pro-
teasomal degradation, it is beginning to be appreciated as a
means for functional modifications including receptor downmo-
dulation, protein-protein interactions, or gene transcription
(Chen and Sun, 2009).
One of the well-characterized RING-type E3 families in the
immune system is the family of Cbl proteins including Cbl,
Cbl-b, and Cbl-c (Thien and Langdon, 2001). Loss of Cbl-b
results in hyperresponsiveness and full T cell activation in the
absence of CD28 costimulation (Bachmaier et al., 2000; Chiang
et al., 2000). Cbl-b acts as an E3 ligase for a number of intracel-
lular molecules such as phosphatidylinositol 3 (PI3) kinase and
affects the recruitment of PI3 kinase to the upstream molecules
(Fang and Liu, 2001). Itch is an example of HECT-type E3 ligase
whose mutation results in abnormal immunological and inflam-
matory responses, leading to skin-scratching itchy phenotype
(Perry et al., 1998). Itch has been shown to target Jun family
proteins c-Jun and JunB and influence T cell proliferation and T
helper type 2 (Th2) cell cytokine production (Fang et al., 2002).
In addition, Itch is functionally regulated by upstream kinases
via direct phosphorylation (Gao et al., 2004; Yang et al., 2006).
Previous studies have suggested that Itch and Cbl-b are
involved in the process of T cell tolerance induction via inducing
T cell anergy (Heissmeyer et al., 2004; Jeon et al., 2004; Venu-
prasad et al., 2006) and by regulating Foxp3 expression in
induced regulatory T cells (Venuprasad et al., 2008). In addition,
a previous biochemical study has shown that a Cbl family
protein, Cbl-c, and perhaps other Cbl members, physically
interact with Itch (Courbard et al., 2002). Intriguingly, it was
also shown that HECT-type E3s like Nedd4 or Itch were shown
to target Cbl or Cbl-b for ubiquitination and subsequent degra-
dation (Magnifico et al., 2003; Yang et al., 2008). Thus, the exact
biological function of the Itch and Cbl-b interaction remains to be
established. Here, we provide genetic evidence that deletion of
both Cbl-b and Itch leads to augmented T cell activation and
spontaneous autoimmunity. Surprisingly, the double-deficient
T cells display augmented phosphorylation of T cell receptor-z
(TCR-z) without affecting its downmodulation. The present study
characterizes Ub K33-linked polyubiquitination of TCR-z, and
points out the important role of unconventional cell surface
receptor ubiquitination in regulating T cell activation in a proteol-
ysis-independent manner.
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Figure 1. Enhanced T Cell Activation and
Spontaneous Autoimmunity in Double-Defi-
cient Mice
(A) Histology of various tissue sections from wild-
type (WT), Cblb/, Itch-/-, or Cblb/Itch-/-
double-deficient mice (3 months old), visualized
by HE staining (original magnification 103). The
sites with lymphocyte infiltration were marked by
an asterisk.
(B) Concentrations of serum anti-double-stranded
(ds) DNA antibodies were determined by ELISA.
(C) Concentrations of serum TNF-a or IL-6 were
determined by ELISA. The results in (B) and (C)
were from ten mice of each group (from 6 to
14 weeks of age).
(D) Splenic T cells from WT or the mutant mice
were isolated and stimulated with anti-CD3
for 24 hr. Cell proliferation was measured by
3H-thymidine uptake.
(E) The supernatants from 48 hr culture with
anti-CD3 (1 mg/ml) or anti-CD3 plus anti-CD28
(10 mg/ml) were collected and measured for IL-2
concentrations by ELISA. Data are representatives
of three repeated experiments.
See also Figures S1 and S2.
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Spontaneous Autoimmunity and Augmented T Cell
Activation in Double-Deficient Mice
In this study,wecrossedCblb/C57BL/6micewith itchy (Itch/)
mice to generate wild-type (WT), Cblb/, Itch/, or Cbl-b and
Itch double-deficient (Cblb/Itch/) mice. The most obvious
observation was the enlarged spleen in 6- to 8 week-old double-
deficient mice, which was 46 times bigger than the WT control
littermates (Figure S1A available online), whereas the spleen
size of Cblb/ mice was similar as WT mice, and the spleen of
Itch/ mice was about two times bigger than the control mice.
The sizes of lymph nodes in double-deficient mice were also
enlarged, as compared with the WT, Cblb/, or Itch/ mice.
The total cell numbers were counted in both spleens and lymph
nodes and showed a proportional increases relative to the sizes
of these lymphoid organs (Figure S1B). We also examined the
percentage of CD4+ or CD8+ T cells in the spleen of double-defi-
cient mice and the ratio of CD4+ versus CD8+ peripheral mature
T cells remained largely unchanged in double-deficient mice, in
comparison to the WT, Cblb/, or Itch/ mice (Figure S1C).
We next performed histological examination of various organs
fromWT and the mutant mice. Although not obvious in the singleImmunity 33, 6gene-targeted mice, there were massive
lymphocyte infiltrations in multiple organs
including the liver, lung, and kidney in
double-deficient mice of 3 months of
age (Figure 1A). The double-deficient
mice also exhibited higher concentrations
of anti-double-stranded DNA antibodies
in the sera compared with the WT,
Cblb/, or Itch/ mice (Figure 1B), sug-
gesting the development of spontaneous
autoimmunity in double-deficient mice.The serum titers of inflammatory cytokines such as TNF-a and
IL-6 were augmented in double-deficient mice (Figure 1C).
In addition, we observed a shift from CD62LhiCD44lo naive pop-
ulation to CD62LhiCD44hi memory or activated population and
increased cell surface expression of CD25 and CD69 activation
markers in double-deficient T cells (Figures S1D–S1F).
Ablation of Cbl-b results in augmented proliferation of periph-
eral T cells in response to TCR stimulation (Bachmaier et al.,
2000; Chiang et al., 2000), whereas Itch deficiency has only a
marginal effect (Fang et al., 2002). To test whether loss of both
Itch and Cbl-b affects the proliferative responses, we measured
the thymidine incorporation of primary splenic T cells. The cell
proliferation of double-deficient T cells was higher as compared
with Cblb/ or Itch/ T cells under anti-CD3 stimulated condi-
tions (Figure 1D). In addition, the double-deficient T cells also
showed stronger proliferative responses under conditions stim-
ulated with anti-CD3 plus anti-CD28 (Figure S2A).
Because of the shift from naive to memory or activated
T cell phenotype in the double-deficient mice, we sorted the
CD4+CD44lo naive population and performed a similar prolifera-
tion experiment. We found that double-deficient T cells exhibited
a higher proliferative response to anti-CD3 plus anti-CD28 stim-
ulation (Figure S2B). The double-deficient T cells producedmore0–70, July 23, 2010 ª2010 Elsevier Inc. 61
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Figure 2. Altered Intracellular Signaling and
Normal TCR Downmodulation in Double-
Deficient T Cells
(A) Purified CD4+ T cells were stimulated with anti-
CD3 for 5 min, and the cell lysates were subjected
to immunoblotting with phospho-tyrosine (pY) anti-
body (4G10). Molecular size markers are shown at
left. The positions of several proteins were indi-
cated. A longer exposure of the same blot was dis-
played for indicating the phosphorylation of TCR-z.
The blot was reprobedwith anti-Grb2 as an internal
loading control of the samples.
(B) Purified CD4+ T cells were stimulated with anti-
CD3 (min), and the cell lysates were analyzed by
probing with different antibodies. For the measure-
ment of phospho-SLP-76, the cell lysates were im-
munoprecipiated with anti-SLP-76 and were sub-
jected to probing with pY antibody.
(C) TCR downregulation. Purified CD4+ T cells
were stimulated with anti-CD33 (2 mg/ml) for dif-
ferent time periods; this was followed by FACS
analysis of the cell surface TCR expression. The
percentage of TCR downmodulation was shown.
T cells were pretreated with cycloheximide (50 mM)
for prevention of new protein synthesis. Data are
representatives of five repeated experiments.
(D) Ligand-independent internalization of TCR.
Purified CD4+ T cells were first labeled with PE-
anti-TCR-b and incubated at 37C for different
time periods. The surface uninternalized PE-anti-
TCRb was removed by brief stripping with acidic
buffer. The intracellular fluorescence was mea-
sured by flow cytometry. The percentage of TCR
internalization was shown. The mean of tripli-
cate experiments from different mice was pre-
sented. Data are representatives of five repeated
experiments.
See also Figure S3.
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stimulation measured by ELISA (Figure 1E) or intracellular stain-
ing (Figure S2C). Taken together, the results suggest that Cbl-b
and Itch cooperate to regulate T cell proliferation and IL-2 pro-
duction. In addition, we observed an increased production of
IFN-g and IL-4 cytokines in double-deficient T cells (Figure S2D).
Increased T Cell Signaling but Normal TCR
Downmodulation in Double-Deficient T Cells
We then investigated the intracellular biochemical events in WT,
single-deficient, and double-deficient peripheral T cells. Anti-
CD3 stimulation for a short period of time (5 min) slightly
enhanced the overall tyrosine phosphorylation of intracellular
signaling proteins (Figure 2A). A longer exposure of the immuno-
blot exhibited a marked increase in TCR-z phosphorylation,
which led to an increased migration at a molecular mass of
23 kDa in double-deficient T cells, whereas such an increase
was not observed in Cblb/ or Itch/ T cells. Further analysis
of the phosphorylation status of downstream intracellular sig-
naling components revealed that phosphorylation of Zap-70,
Erk, JNK, LAT, Vav, and SLP-76, but not Lck or PLC-g1, was
also enhanced in double-deficient T cells after stimulation
(Figure 2B). It should be mentioned that we also examined62 Immunity 33, 60–70, July 23, 2010 ª2010 Elsevier Inc.whether deficiency of both Cbl-b and Itch affects the protein
stability of several signaling proteins. It seems that double-defi-
cient T cells contain very similar protein amounts of PKCq and
Cbl as WT T cells (data not shown).
Ub conjugation of cell surface receptors has been implicated
in endocytosis-dependent downregulation (Hicke and Dunn,
2003). Cbl proteins like Cbl and Cbl-b are involved in the internal-
ization of the TCR (Myers et al., 2006; Naramura et al., 2002). The
enhanced phosphorylation of TCR-z and increased intracellular
signaling in double-deficient T cells prompted us to analyze
whether loss of both E3 ligases affects the TCR endocytotic
pathway. The cell surface expression of TCRb or CD33 was
equivalent among the resting CD4+ T cells from WT, Itch/,
Cblb/, or double-deficient T cells (Figure S3A). Stimulation of
purified CD4+ T cells with anti-CD3 induced rapid downmodula-
tion of the TCR, as measured by cell surface staining with anti-
TCR-b in WT, Itch/, or Cblb/ cells (Figure S3B). Unexpect-
edly, the rate of TCR downmodulation in double-deficient
T cells was quite similar, if not the same, as other types of
T cells, even upon repeated experiments. To avoid the potential
interference of newly synthesized protein, we preincubated the
cells in the presence of a protein synthesis inhibitor, cyclohexi-
mide, and observed similar rate of downmodulation among all
Immunity
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Itch double deficiency affected the ligand-independent internal-
ization of the TCR by using a previously described method
(D’Oro et al., 2002) and found that T cells from double-deficient
mice exhibited a similar rate of internalization as WT or single
gene-targeted cells (Figure 2D). Thus, we conclude that Cbl-b
and Itch regulate the phosphorylation of TCR-zwithout affecting
its downmodulation.
Cbl-b and Itch Cooperate to Regulate TCR-z
Ubiquitination and Phosphorylation
TCR-z is a well-characterized substrate for Ub conjugation (Cen-
ciarelli et al., 1992; Wang et al., 2001). The increased T cell
signaling, particularly the upregulated TCR-z phosphorylation,
prompted us to examine Ub conjugation to TCR-z by Cbl-b
and Itch in transiently transfected Jurkat T cells upon T cell stim-
ulation. In the presence of Itch and Cbl-b, TCR-z ubiquitination
was augmented when cells were stimulated with anti-CD3
(Figure 3A), which caused a shift from lower-molecular-weight
bands to higher-molecular-weight smears. To avoid the interfer-
ence of other T cell-associated components in Jurkat T cells, we
also used human embryonic kidney 293T cells for the transfec-
tion study and showed that TCR-z ubiquitination was augmented
by coexpression of both Itch and Cbl-b, which was further
increased by the treatment with a phosphatase inhibitor, perva-
nadate (Figures S3C and S3D). In addition, a TCR-z mutant that
lacks all lysine residues on its intracellular tail (TCR-z KR) was
not ubiquitinated in the presence of both Cbl-b and Itch even
under stimulated conditions (Figure S3E). We therefore con-
cluded that Itch and Cbl-b cooperate to induce TCR-z chain
ubiquitination.
The relatively normal amount of TCR downmodulation in
double-deficient T cells led us to examine the degradation of
TCR-z. Purified CD4+ T cells were stimulated with anti-CD3 in
the absence or the presence of cycloheximide and TCR-z
expression was analyzed by immunoblotting. Quantitative anal-
ysis suggested no obvious difference in TCR-z degradation
between WT and double-deficient T cells in the absence of
cycloheximide pretreatment (Figure 3B, top panels). In the pres-
ence of the protein synthesis inhibitor, double-deficient T cells
showed a slight increase of the TCR-z protein expression, which
was not considered to be significant upon repeated experiments
(Figure 3B, bottom panels). We also performed a protein degra-
dation assay in transiently transfected Jurkat T cells. Coexpres-
sion of Cbl-b and Itch did not lead an obvious change in the rate
of TCR-z degradation upon TCR stimulation for a period of 5 hr
(Figure 3C), further supporting our findings of normal TCR-z
degradation in double-deficient T cells.
The increased phosphorylation of TCR-z in double-deficient
T cells raised an issue of whether the two E3 ligases cooperate
to affect the phoshorylation status of TCR-z without affecting
TCR downmodulation. We found that coexpression of Cbl-b
and Itch markedly reduced anti-CD3-induced tyrosine phos-
phorylation of TCR-z (Figure 3D). Phosphorylated TCR-z
recruits Zap-70 to initiate downstream TCR signaling upon
TCR triggering (Weiss and Littman, 1994). To further confirm
the early observation on TCR-z phosphorylation, we performed
a coimmunoprecipitation assay with anti-Zap-70 and examined
the amount of associated TCR-z. Consistent with the earlierresults, we observed that more TCR-z was coimmunopreciated
with anti-Zap-70 in anti-CD3-stimulated double-deficient
T cells (Figure 3E) compared to WT cells. We further investi-
gated the ubiquitination status of endogenous TCR-z and found
that ubiquitin conjugation to TCR-z was substantially reduced
in double-deficient T cells (Figure 3F) compared to WT or
single-deficient T cells. Taken together, these results indicate
that Cbl-b and Itch act cooperatively to regulates TCR-z ubiq-
uitination and phosphorylation in a proteolysis-independent
manner.
K33-Linked Polyubiquitination of TCR-z
We next performed a detailed investigation of Cbl-b- and Itch-
induced ubiquitination of TCR-z and concluded that Cbl-b and
Itch cooperate to induce TCR-z polyubiquitination, which
depends on the E3 ligase activity of Itch and a C-terminal frag-
ment of Cbl-b (Figure S4 and Supplemental Results). We then
examined TCR-z polyubiquitination and found that the polyubi-
quitinated TCR-z was not recognized by an Ub K63-specific
antibody (Figure 4A and Figure S5A). To dissect which Ub lysine
residue is responsible for the poly-Ub chain formation on TCR-z,
we generated a series of Ub mutations on all seven lysine resi-
dues by leaving only one lysine residue on the Ub molecule
(Figure S5B). Among all the Ubmutants, UbK33-onlymutant dis-
played the strongest poly-Ub chain formation on TCR-z (Fig-
ure 4B). This finding was further confirmed with a Ub K33R
mutant, which completely abolished TCR-z polyubiquitination,
whereas the K48-63R double mutant did not have an effect
(Figure 4C). The presence of Ub K33-linked chain formation on
endogenous TCR-z was analyzed by mass spectrometry and
both K33-linked peptide and TCR-z peptide were revealed in
the trypsin-digested samples of K33 Ub affinity purification
(Figure 4D and Figures S5C and S5D), thus providing further
physical evidence of K33-linked TCR-z polyubiquitination. These
results indicate that TCR-z is conjugated with a poly-Ub chain,
which is linked by a previously not-well-characterized K33 conju-
gation of Ub molecules.
K33 Linkage Affects TCR-z Phosphorylation
The effect of Ub K33-linked TCR-z polyubiquitination on its
phosphorylation was examined by cotransfection studies in
Jurkat T cells. For this purpose, we tested the various Ub
mutants with only one lysine residue (Figure S5B). TCR-z phos-
phorylation was markedly reduced by co-expression with WT
Ub or Ub K33-only mutant, whereas the K48-only or K63-only
mutant did not have any effect (Figure 5A). In addition, Ub
K33-only mutant expression reduced the association between
TCR-z and Zap-70 in stimulated Jurkat T cells in the presence
of Cbl-b and Itch (Figure 5B). Strikingly, coexpression of the Ub
K33-only mutant almost completely abrogated anti-CD3-stimu-
lated Zap-70 phosphorylation, without any alteration of Lck
phosphorylation (Figure 5C). To further substantiate these find-
ings, we compared the Ub K33-only to K33R mutant and found
that Ub K33R did not have an effect on TCR-z phosphorylation
(Figure 5D). These biochemical data essentially recapitulate
the enhanced TCR-z phosphorylation and its association with
Zap-70 that is seen in double-deficient T cells. These events
are most likely induced by K33-linked polyubiquitination of
TCR-z.Immunity 33, 60–70, July 23, 2010 ª2010 Elsevier Inc. 63
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Figure 3. Itch and Cbl-b Cooperate to Promote TCR-z Ubiquitination without Degradation
(A) Plasmids as indicated were transfected into Jurkat T cells, and the cells were unstimulated or stimulated with OKT3 for 5 min. Afterward, TCR-z ubiquitination
was analyzed. Molecular size markers were labeled. The Ub ladders are indicated. The membrane was reprobed with anti-Myc, and the lysates was immuno-
blotted with indicated antibodies.
(B) Primary T cells were stimulated with anti-CD33 for different time intervals (hr) in the absence or the presence of cycloheximide, the cell lysates were immuno-
blottedwith anti-TCR-z , and the samemembrane was reprobedwith anti-Grb2. The intensity of the protein bands was quantified and the relative amount of TCR-
z at each starting point of stimulation (0) was given an arbitrary unit of 1.0.
(C) Jurkat T cells were transfectedwith plasmids as indicated, the cells were stimulatedwith OKT3 for different time intervals in the presence of cycloheximide, the
lysates were immunoblotted with anti-Myc, and the samemembrane was reprobed with indicated antibodies. The intensity of TCR-zwas quantified and the rela-
tive amount of TCR-z at time 0 was given an arbitrary unit of 1.0.
(D) Transfected Jurakt T cells were stimulated with anti-CD3 for 2 min, and the lysates were analyzed with the indicated antibodies.
(E) Tcells fromWTordouble-deficientmicewere left unstimulatedor stimulatedwithanti-CD3 for5min, and thecell lysateswere immunoprecipitatedwithanti-Zap-
70. The immunoprecipitateswere immunoblottedwith anti-pY. Theposition of phosphorylatedTCR-zwas indicated. The sameblotwas reprobedwith anti-Zap-70.
(F) Splenocytes from 8-week-oldWT,Cblb/, Itch/ or double-deficientmicewere stimulatedwith anti-CD3 for 5min and lysateswere immunoprecipitatedwith
anti-TCR-z and then immunoblotted with anti-Ub. Molecular size markers are indicated at left.
See also Figure S3.
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Figure 4. K33-Linked Polyubiquitination of TCR-z
(A) Jurkat T cells were transfected with the indicated plasmids, stimulated with anti-CD3, and subsequently immunoprecipitated and blotted with indicated anti-
bodies. Molecular size markers are indicated. A short exposure of TCR-z blot is also shown.
(B) Jurkat T cells were coexpressed with individual Ub mutant, and the TCR-z ubiquitination was analyzed by immunoprecipitation and blotting. Molecular size
markers are shown at left.
(C) Effects of Ub K48-63R double, or K33R single mutation on TCRz polyuniquitination. Molecular size markers are indicated at left.
(D) Tandem mass spectrum of a peptide derived from TCR-z. K33 Ub-linked mixture was purified with Ni-NTA beads and was subjected to mass spectrometry.
The fully tryptic peptide unambiguously identified the peptide sequence corresponding to GHDGLYQGLSTATK of TCR-z.
See also Figures S4 and S5.
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K33-Linked Ubiquitination in T Cell SignalingIdentification of TCR-z K54 as an Ub Conjugation Site
There are seven lysine residues in the TCR-z intracellular domain
that are conserved across different species. We generated
a series of single or combinatory mutations in TCR-z to map
the potential Ub conjugation site(s) in coexpression studies.
Mutation of K54 within the TCR-z resulted in the most drastic
reduction of TCR-z ubiquitination, particularly in the polyubiquit-
nated form in the presence of Cbl-b and Itch (Figure 6A and
Figures S6A and S6B). To provide further biophysical evidence,
we performed proteomics analysis by using immunoprecipitated
TCR-z and found a modified TCR-z peptide sequence spanning
the K54 residue, in which a mass increase of 114 dalton was de-
tected (Figure 6B and Figure S6C). This increase of molecular
mass over the unmodified peptide corresponded to the two
C-terminal glycine residues derived from Ub attached to K54.
We went further to examine the effect of K54 mutation on its
phosphorylation and complex formation. Compared with WT
TCR-z, the TCR-z K54R mutant exhibited enhanced phosphory-
lation in response to anti-CD3 stimulation (Figure 6C). In addi-
tion, this mutation increased the phosphorylation of Zap-70,
but not that of Lck (Figure 6D). More strikingly, the K54 to R
mutation markedly enhanced anti-CD3-induced association
between TCR-z and Zap-70 (Figures 6E and 6F). The resultssuggest that K33-linked poly-Ub chain formation on TCR-z
K54 residue affects its phosphorylation and association with
Zap-70.
DISCUSSION
In this study, we provided both genetic and biochemical evi-
dence to support the hypothesis that Itch and Cbl-b cooperate
to regulate T cell activation and autoimmunity. We demonstrated
that loss of both Cbl-b and Itch increases the phosphorylation of
TCR-z without affecting TCR downmodulation and degradation.
Further biochemical studies reveal that TCR-z is polyubiquiti-
nated via an Ub K33 linkage, and such a result reduces its asso-
ciation with Zap-70. Mutation at TCR-z K54 polyubiquitination
site rescues the reduced TCR-z and Zap-70 phosphorylation
and restores their association. The results suggest an unconven-
tional polyubiquitination pathway that is critical for the regulation
of cell surface receptor in a proteolysis-independent manner.
The present study clearly suggests that Cbl-b and Itch coop-
erate with each other to regulate T cell signaling transduction,
as evidenced by the increased tyrosine phosphorylation of
TCR-z and other downstream intracellular critical signal mole-
cules upon TCR stimulation. The increased signal transductionImmunity 33, 60–70, July 23, 2010 ª2010 Elsevier Inc. 65
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Figure 5. Effect of K33-Linked Polyubiquiti-
nation on TCR-z
(A) K33-linked ubiquitination of TCR-z inhibits its
phosphorylation. Jurkat T cells transfected with
indicated plasmids were stimulated for 2 min,
lysed, and blotted with indicated antibodies.
(B) Effect of Ub K33 on TCR-z interaction with
Zap-70. Jurkat T cells transfected with indicated
plasmids were stimulated with anti-CD3 for
10 min, and the lysates were immunoprecipitated
with anti-Zap-70 and blotted with anti-Myc.
Aliquots of cell lysates were blotted with indicated
antibodies in each panel.
(C) K33-linked ubiquitination of TCR-z inhibits
Zap-70 phosphorylation. Jurkat T cells transfected
with indicated plasmids were stimulated with
OKT3 for 1 to 10 min, and the lysates were blotted
with indicated antibodies.
(D) K33 is the major linkage that is responsible for
the inhibition of phosphorylation of TCR-z and
Zap-70. Jurkat T cells transfected with indicated
plasmids were stimulated with OKT3 for 1 to
10 min and the lysates were blotted with indicated
antibodies.
Immunity
K33-Linked Ubiquitination in T Cell Signalingevents in the double-deficient T cells attribute to augmented
T cell proliferation and IL-2 production. Excessive T cell activa-
tion in the double-deficient mice correlates with lymphocyte infil-
tration in multiple organs and the development of autoimmunity,
as revealed by the presence of higher amounts of autoantibodies
in the sera of double-deficient mice. It should be mentioned that
such autoimmune phenotypes are observed in an early age
when neither Cblb/ nor Itch/mice exhibit any obvious alter-
ation, thus consisting with a notion that the two proteins func-
tions in a cooperative manner.
One surprising finding in this study is that TCR downmodula-
tion was not affected by Cbl-b and Itch double deficiency.
Although in our earlier preliminary studies using unpurified
splenic T cells a slight decrease in TCR downregulation was
observed in double-deficient T cells (data not shown), repeated
experiments using similar splenic T cells or purified CD4+ or
CD8+ T cells convincingly showed that T cell stimulation results
in similar, if not the same, rate of TCR endocytosis among
WT, single-deficient, or double-deficient T cells. In addition,
the ligand-independent TCR internalization in double-deficient
T cells is the same as in WT or single-deficient T cells. Even
though it is generally believed that Ub conjugation to the cell
surface receptor leads to its endosome-lysosome-dependent
downmodulation (Hicke and Dunn, 2003), our data clearly
suggest that this is not the case for the ubiquitination of TCR-z
promoted by a cooperative act of Cbl-b and Itch. It can be
argued that TCR-z is polyubiquitinated, rather than monoubiqui-
tinated, as revealed in our biochemical analysis, which may lead
to proteasome-dependent degradation instead of endosome-
dependent endocytosis. This possibility has been ruled out,
however, given that both genetic and biochemical experiments
showed that a combination of Cbl-b and Itch does not affect
protein degradation of TCR-z. The results appear to differ from
those obtained in Cbl/Cblb/ T cells in which ligand-induced66 Immunity 33, 60–70, July 23, 2010 ª2010 Elsevier Inc.TCR downregulation is reduced (Naramura et al., 2002).
However, Cbl (or Cbl-b) also regulates receptor internalization
in an E3 ligase-independent mechanism (Petrelli et al., 2002;
Soubeyran et al., 2002) or via interacting with other adaptor
proteins (Myers et al., 2005; Myers et al., 2006), which may differ
from the cooperative function between Cbl-b and Itch.
Importantly, we demonstrated that TCR-z is conjugated with
a poly-Ub chain via a K33 linkage, which affects its phosphory-
lation and association with Zap-70, as revealed in coexpression
studies with a Ub K33 mutant. More importantly, the identifica-
tion of TCR-z K54 as a potential Ub conjugation site and subse-
quent analysis further supports the hypothesis that K33-linked
polyubiquitination of TCR-z critically regulates the status of its
phosphorylation and Zap-70 association, without any effect on
the upstream kinase Lck. These biochemical studies essentially
recapitulate the increased tyrosine phosphorylation of TCR-z
and Zap-70 binding observed in double-deficient T cells. It is
possible that K33-linked Ub conjugation to TCR-z may cause
a structural hindrance for the access of Zap-70 binding. This
effect is selective, given that neither double-deficient T cells
nor transiently transfected T cells display any alteration in Lck
phoshorylation. Support of this possibility is the observation
that ubiquitination of the p85 subunit of PI3 kinase negatively
affects its interaction with CD28 or the TCR complex (Fang
and Liu, 2001). Similarly, TCR-z polyubiquitination interferes
with recruitment of Zap-70, a direct binding partner for the phos-
phorylated TCR-z (Weiss and Littman, 1994). It has been demon-
strated that the recruitment of Zap-70 to the TCR-z could protect
TCR-z from dephosphorylation (van Oers et al., 1994), which
most likely explain the increased TCR-z phosphorylation in
double-deficient T cells.
Each of the seven lysine residues in Ub has been demon-
strated to be used for Ub conjugation (Pickart and Fushman,
2004), which may lead to different biological outcomes. The
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Figure 6. The Juxtamembrane K54 in TCR-z
Is the Acceptor Site for the K33-Linked Poly-
ubiquitination
(A) TCR-z K54Rmutation reduces its ubiquitination
by Itch and Cbl-b. TCR-z or its K54R mutant was
coexpressed with Itch, Cbl-b, and Ub plasmids
and then TCR-z ubiquitination was detected.
Molecular size markers are indicated at left.
(B) Affinity-purified TCR-zmixtures were subjected
to mass spectrometry. Tandem mass spectrum
of ubiquitinated peptide derived from TCR-g: LFL
RVK#FSRSADAPAYQQGQNQLYNELNLGR, with
the precursor ion mass 1239.46. The half tryptic
peptide identified TCR-g ubiquitination site at
lysine 54 with a mass addition of 114. The exis-
tence of site localization ions on both side of K54,
e.g., b6 and above, and neutral loss of y26,
supports the modification event on K54. ‘‘#’’
denotes the residue on its left had a mass addition
of 114.
(C) TCR-z K54R mutation reverses the inhibitory
effect of K33 ubiquitination. TCR-z or its K54R
mutant was coexpressed with indicated plasmids
and stimulated with anti-CD3. The lysates were
immunoprecipitated with Myc antibody and blot-
ted with anti-pY to detect TCR-z phosphorylation.
(D) The lysates as in (C) were blottedwith phospho-
specific antibodies for Zap-70 or Lck.
(E and F) TCR-z K54R mutant shows increased
interaction with Zap-70. Jurkat T cells transfected
with indicated plasmids were stimulated with
anti-CD3 for 10 min and then immunoprecipitated
and blotted as indicated.
See also Figure S6.
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K33-Linked Ubiquitination in T Cell Signalingclassical K48-linked polyubiquitination targets the substrate for
proteasomal degradation, whereas the K63-linked chains are
involved in nonproteolytic regulation such as protein complex
formation and kinase activation (Chen and Sun, 2009). An
emerging mechanism for proteasome-dependent degradation
involves the K11-linked poly-Ub chain in yeast, which targets
Ubc6 for ER-associated degradation (Xu et al., 2009). Interest-
ingly, profiling of the entire yeast proteome in this study reveals
that the K33 linkage is relatively resistant to proteasomal degra-
dation and only slightly weaker than the K63 linkage. A recent
study implicated a K29-K33-linked chain formation in regulating
AMP-activated protein kinase-related kinases (Al-Hakim et al.,
2008). These observations are thus consistent with our finding
in T cells that K33-linked polyubiquitination of TCRz is indepen-
dent of proteasomal or endosomal degradation. Future proteo-Immunity 33, 6mics studies will aim at the identification
of more physiological substrates for K33-
linked polyubiquitination, the elucidation
of the molecular mechanisms underlying
this unconventional modification, and
the investigation of the implicated biolog-
ical functions.
In conclusion, loss of a RING-type E3
ligase Cbl-b and a HECT-type E3 ligase
Itch results in increased T cell activation
and autoimmune responses. The two E3ligases cooperate to induce K33-linked polyubiquitination of
TCR-z, which functionally modifies the receptor phosphoryla-
tion and protein binding in a proteolysis-independent manner.
Further elucidation of such Ub chain formation will help under-
stand the molecular insights into the protein ubiquitination
pathway in immune regulation.
EXPERIMENTAL PROCEDURES
Mice
Cblb/ and Itch/ mice on a C57BL/6 background were described previ-
ously (Fang et al., 2002; Fang and Liu, 2001). We crossed the mice to generate
Itch+/Cblb+/ double heterozygous mice that were intercrossed to obtainWT,
heterozygous, single, and double-deficient mice. Genotyping of the mice was
performed by PCR for the detection of Itch mutation and by Southern blotting
for the detection of Cbl-b mutation with tail DNA. Mice of 6 to 14 weeks old0–70, July 23, 2010 ª2010 Elsevier Inc. 67
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K33-Linked Ubiquitination in T Cell Signalingwere used for the experiments, unless otherwise specified. The double-
deficient mice did not develop any apparent abnormality at least at 4 months
of age in the animal facility. Animal experiments were carried out according to
the institutional guidelines approved by the institute ethical committee.
Cell Proliferation and Cytokine Production
Single-cell suspensions isolated from spleen or lymph nodes or purified CD4+
or CD8+ were cultured in the presence of anti-CD3 and/or anti-CD28. Purifica-
tion of naive CD4+ T cells was performed as described (Venuprasad et al.,
2006). Proliferation of last 12 hr of 48 hr culture was detected by addition of
1 mCi of 3H-thymidine (ICN), and cell-incorporated radiation was monitored
by b-counter (Wallac). The culture supernatants were collected and assayed
for the concentrations of IL-2 by standard ELISA.
Plasmids and Cell Transfection
Plasmids containing Xpress-tagged Cbl-b; Cbl-b WA, its N-terminal mutant
encoding the N-terminal domain (Cbl-b N, amino acids 1 to 349); a C-terminal
mutant encoding the RING finger plus the proline-rich region (Cbl-b C1, amino
acids 341 to 982); or C-terminal mutant encoding only the distal proline-rich
sequences (Cbl-b C2, amino acids 595–982), Itch, Itch ligase-inactive (Itch
CA), Itch mutant lacking the HECT domain (Itch WW), Myc-TCR-z, or HA-Ub
cDNA were described previously (Fang et al., 2001; Wang et al., 2001). Ub
mutants were generated by introducing point mutations from HA-Ub with all
lysine mutated (K0) construct with Quikchange Mutagenesis kit (QIAGEN)
with the following primer sets: (UbK6-F: 50-GCAGATCTTCGTCAAAACGTTA
ACCGGTAG-30; UbK6-R: 50-CTACCGGTTAACGTTTTGACGAAGATCTGC-30;
UbK11-F: 50-GAACGTTAACCGGTAAAACCATAACTCTAG-30; UbK11-R:
50-CTA GAGTTATGGTTTTACCGGTTAACGTTC-30; UbK27-F: 50-CCATCGA
AAACGTTAAAGCTAGA ATTCAAGAC-30; UbK27-R: 50-GTCTTGAATTCTAGC
TTTAACGTTTTCGATGG-30; Ub29K-F: 50-GA AAACGTTAGAGCTAAAATTC
AAGACAGAGAAG-30; Ub29K-R: 50-CTTCTCTGTCTTGAATTT TAGCTCTAA
CGTTTTC-30; UbK33-F: 50-GCTAGAATTCAAGACAAAGAAGGCATTCCACC
TG-30; UbK33-R: 50-CAGGTGGAATGCCTTCTTTGTCTTGAATTCTAGC-30;
UbK48-F: 50-GATCTTTGC CGGTAAGCAGCTCGAGGACGG-30; UbK48-R:
50-CCGTCCTCGAGCTGCTTACCGGCAAAG ATC-30; UbK63-F: 50-GATTAC
AACATTCAGAAGGAGTCGACCTTAC-30; UbK63-R: 50-GTAAG GTCGACTC
CTTCTGAATGTTGTAATC-30). UbDGG was mutated from HA-Ub with the
following primer set: (UbDGG-F: 50-GTCTTAAGACTAAGATGAGGTTGAACG
CGTGGTACC-30; UbDGG-R: 50-GGTACCACGCGTTCAACCTCATCTTAGTC
TTAAGAC-30). TCR-z K54R mutation was generated with the following primer
set: (TCR-KR1-F: 50-CTTGTTCCTGAG AGTGAGGTTCAGCAGGAGC-30;
TCR-KR1-R: 50-GCTCCTGCTGAACCTCACTCTCAGGAA CAAG-30). A TCR-z
KR mutant in which all nine intracellular lysine residues were mutated to argi-
nine was generated by multistep site-directed mutagenesis. All the mutations
were verified by DNA sequencing.
For protein expression in 293T cells or the human Jurkat T cells, cells were
transfected with appropriate amounts of plasmids (usually 35 mg total) by
electroporation (240V, 960 mF; Bio-Rad) with Fugene 6 transfection reagent
(Roche).
Antibodies
Polyclonal antibodies specific to Cbl-b, Zap-70, PLC-g1, Erk, JNK, Vav, Myc,
Ub, and HA, and monoclonal antibody (mAb) specific to TCRz (6B10) were
purchased from Santa Cruz Biotechnology. A polyclonal antisera against
TCR-z (551-z), was gift from D. Wiest, Fox Chase Cancer Center, Philadelphia,
PA. Antibodies against SLP-76, LAT, and phospho-LAT were from Upstate.
mAbs specific to phospho-ERK, phospho-JNK, phospho-Zap-70, phospho-
PLC-g1, Itch, and Grb2 were purchased from Transduction Laboratories.
Rabbit anti-Lck and anti-phospho-Src (Y418) were purchased from Cell
Signaling. Anti-Xpress was from Invitrogen. Mouse anti-Ub K63 (HWA4C4)
was purchased from Biomol. Secondary anti-mouse Ig conjugated with FITC
or Rhodamine and anti-rabbit Ig conjugated with FITC and Rhodamine were
from Oraganon Teknika Corp. Phosphotyrosine specific mAb was purified
from culture supernatant of 4G10 B cell hybridoma. The T cell stimulatory
mAb, anti-CD33, was purified from the culture supernatant of B cell hybrid-
omas 2C11. Biotin-labeled TCRb-specific mAb was purchased from PharMin-
gen. Anti-TCR-z mAb H146-968 was provided by R. Kubo in our institute.68 Immunity 33, 60–70, July 23, 2010 ª2010 Elsevier Inc.Immunoprecipitation and Immunoblotting
Immunoprecipitation was performed by incubation of the cell lysate with 1 mg
of antibody at 4C for 2 hr, followed by addition of 30 ml of protein G-conju-
gated Sepharose beads (Santa Cruz Biotechnology). For displaying ubiquiti-
nated protein, 1.0% SDS and 5 mM N-ethylmaleimide were added to lysis
buffer for disruption of nonspecific protein interactions. Precipitated protein
was denatured by boiling for 10 min and then diluted to 0.1% SDS before
immunoprecipitation (Venuprasad et al., 2008). Samples were subjected to
8%10% SDS-PAGE separation, followed by electro-transferring to PVDF
membrane (Millipore). Membrane was immunoblotted with the indicated anti-
bodies and then horseradish peroxidase-conjugated second antibody and
visualized with enhanced chemiluminescence detection system (ECL, Amer-
sham Pharmacia). When necessary, the membrane was stripped as previously
described (Yang et al., 2006).
Flow Cytometry
Prior to FACS staining, 106 cells were incubated on ice for 30 min in 100 ml of
10% FCS media containing 2 mg/ml of anti-FcgR (2.4G2, PharMingen). Then,
the cells were washed and stained on ice with 1:100 diluted labeled antibodies
for 1 hr and analyzed on a FACScalibur or a FACS-LSRwith the CellQuest soft-
ware (Becton Dickinson). The following antibodies were used for staining:
FITC-, PE-, APC-, or CyC-conjugated antibodies against murine CD4, CD8,
TCRb, CD33, CD5, CD25, CD44, CD62L, or CD69 (PharMingen).
TCR Downregulation and Internalization
For TCR downregulation experiment, purified CD4+ or CD8+ T cells (106/
sample) were cultured with 2 or 5 mg/ml of anti-CD33 for various times in
96-well plate. For prevention of the interference of newly synthesized proteins,
T cells were pretreated with cycloheximide for 2 hr. The cell surface expression
of TCRb was analyzed by FACS analysis. For ligand-independent TCR inter-
nalization assay, we followed a previously published protocol (D’Oro et al.,
2002). In brief, 23 106 CD4+ or CD8+ T cells were first labeled with PE-conju-
gated anti-TCRb antibody and the cells were then incubated at 37C for
different time intervals. The uninternalized TCRb-PE was removed by a brief
stripping with ice-cold acidic buffer. The intracellular fluorescence was
measured by FACS analysis.
Purification of K33 Ubiquitinated Proteins
Jurkat T cells (23108) overexpressing His-HA-Ub K33, Itch, and Cbl-b (or Itch
and Cbl-b only as control) were first lysed with a denaturing buffer (50 mM
NaH2PO4, 300 mM NaCl, 10 mM imidazole, 0.5% NP-40, and 8 M Urea
[pH 8.0]) by passing 21G needle 15 times. Clarified lysates were added with
200 ml Ni-NTA agarose beads (QIAGEN) and incubated at 4C for 2 hr. Beads
were washed with a washing buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM
imidazole, and 8MUrea [pH 8.0]) four times. Bound Ub conjugages were step-
eluted by increase of imidazole concentrations (30, 40, 50, and 250 mM) in
washing buffer. Most polyubiquitinated products were eluted at 40 mM imid-
azole. The samples were then directly preceded for trypsin digestion and
Mass Spec analysis.
Proteomic Identification of K33 Ubiquitinated Proteins
Protein samples were precipitated with 80% of acetone in 20C for 30 min
and centrifuged at 14,000 3 g for 15 min. The pellets were solubilized in
0.2% RapiGest/10 mM DTT at 60C for 30 min. Iodoacetamide was added
to a final concentration of 15 mM and incubated at room temperature for
20min in dark. The suspension was then diluted to a final RapiGest concentra-
tion of 0.1% with 100 mM Tris-HCl and 1 mM CaCl2. The proteins were
digested with 1 mg of trypsin at 37C overnight. After digestion, the suspension
was acidified by adding formic acid to 5% and centrifuged. The solution con-
taining peptides were then used for protein identification.
Peptides from each sample were pressure-loaded onto a 250 mm internal
diameter (i.d.) fused silica capillary column packed with a 3 cm, 5 mm Parti-
sphere strong cation exchanger (SCX, Whatman) and a 3 cm, 10 mm Jupiter
reversed-phase C8 material (Phenomenex), with the SCX end fritted with
immobilized Kasil 1624 (PQ Corperation). After desalting, a 100 mm i.d. capil-
lary with a 5 mm pulled tip packed with 10 cm, 4 mm Jupiter C8 material was
attached to a zero dead volume (ZDV) union and the split-column was placed
online with an Agilent 1100 quaternary HPLC system (Agilent) and analyzed
Immunity
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(MudPIT) described previously (Washburn et al., 2001). In brief, three buffer
solutions used were as follows: 5% acetonitrile/0.1% formic acid (buffer A);
80% acetonitrile/0.1% formic acid (buffer B), and 500 mM ammonium
acetate/5% acetonitrile/0.1% formic acid (buffer C). The first step consisted
of a 100 min gradient from 0%–100% buffer B. Steps 2–5 had the following
profile: 3 min of 100% buffer A, 5 min of increasing buffer C concentration
(10%, 30%, 75%, and 100%), a 10 min gradient from 0%–15% buffer B,
and a 82 min gradient from 15%–45% buffer B, followed by a 10 min gradient
increase to 100% buffer B, and a 10 min reverse of gradient to 100% buffer A.
As peptides were eluted from the microcapillary column they were electro-
sprayed directly into an LTQ linear ion trap mass spectrometer (ThermoFinni-
gan) with the application of a distal 2.4 kV spray voltage. A cycle of one full-
scan mass spectrum (400–1400 m/z) followed by five data-dependent MS/
MS scans at a 35% normalized collision energy was repeated continuously
throughout each step of the multidimensional separation.
The resulting MS/MS spectra were searched with the SEQUEST algorithm
(Yates et al., 1995) against a human database from EBI (http://www.ebi.ac.
uk/IPI) that was concatenated to a decoy database in which the sequence
for each entry in the original database was reversed. The mutant Ub sequence
and its reverse sequence were included in the database. The search parame-
ters include a static cysteine modification of 57 amu, a di-glycine modification
of lysine of 114 amu and with half trypsin specificity. The database search
results were assembled and filtered with the DTASelect program (Tabb
et al., 2002) with a spectra level false discovery rate of less than 0.1%. Under
such filtering conditions, no peptide hit from the reverse database was found.
Because the Ub peptide with K33 ubiquitination did not pass the filtering
criteria, we manually annotated the spectra and confirmed Ub conjugation
at K33.
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